BTG3 and COVID-19: found that patients with COVID-19 who have higher anti-NET antibodies are more likely to be detected with positive autoantibodies [e.g., antinuclear antibodies (ANA) and anti-neutrophil cytoplasmic antibodies (ANCA)], suggesting that COVID-19 NETs may act as potential inducers for autoimmune responses (27).